This HTML5 document contains 210 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.3341/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36424457
rdf:type
wikibase:Item
schema:description
2012 nî lūn-bûn mokslinis straipsnis мақолаи илмӣ artikull shkencor επιστημονικό άρθρο مقالهٔ علمی 2012年学术文章 სამეცნიერო სტატია article scientifique (publié 2012) vedecký článok artigo científico (publicado na 2012) vědecký článek article científic 2012年學術文章 наукова стаття, опублікована в листопаді 2012 บทความทางวิทยาศาสตร์ tieteellinen artikkeli ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون 2012年の論文 2012년 논문 artigo científico videnskabelig artikel (udgivet 2012) articol științific 2012年學術文章 vetenskaplig artikel 2012年学术文章 articolo scientifico artykuł naukowy bài báo khoa học 2012年学术文章 teaduslik artikkel 2012年學術文章 научная статья scientific article naučni članak tudományos cikk wissenschaftlicher Artikel bilimsel makale scienca artikolo artículu científicu espublizáu en 2012 vitskapeleg artikkel artikulong pang-agham 2012年学术文章 article scientific artigo científico (publicado na 2012) vitenskapelig artikkel мақолаи илмӣ 2012年學術文章 مقالة علمية نشرت بتاريخ 12-11-2012 מאמר מדעי artículo científico publicado en 2012 2012年學術文章 գիտական հոդված 2012年学术文章 научна статия 2012年學術文章 wetenschappelijk artikel научни чланак научни чланак
p:P577
wds:Q36424457-2CE0EF4C-88F6-4387-A4ED-BF9CD1E56117
wdt:P577
2012-11-12T00:00:00Z
p:P2860
wds:Q36424457-C91F49EB-D6D2-49D5-8544-43A2EFA640C3 wds:Q36424457-D1C0E46C-C11E-435B-9D90-6103E5C6128C wds:Q36424457-D76F6BCD-9D00-40A0-87E7-AD5228ACE810 wds:Q36424457-D7C5FC94-D963-4D51-B7B6-97F696EC46E8 wds:Q36424457-DC03CFF4-FF71-4F84-A17A-6F791E8FEC5B wds:Q36424457-E6AB70EA-20D8-4796-9B4C-FD9279BDD406 wds:Q36424457-EF97AAB1-7CA5-4D99-8E09-155B5DB8535E wds:Q36424457-A9511465-4A96-40D9-983A-DF9A29CD424D wds:Q36424457-B0D3E16C-05D6-4032-9DEE-4DC12B84D765 wds:Q36424457-B226861A-1708-47BB-BD75-42F12E83B7D4 wds:Q36424457-B52842BA-DB2B-42AF-9840-A571F81BFB02 wds:Q36424457-B5B13E30-5316-471F-859A-E3C21A357036 wds:Q36424457-88032414-8831-4DD8-891D-6CB831657CB7 wds:Q36424457-8DF22D96-42C9-4DD1-9B59-A5D0CAF1419E wds:Q36424457-8F5D9086-DBA1-48C7-A75D-43505340B9EA wds:Q36424457-9481D343-27E9-4B3A-8CB0-96BE48AC6B96 wds:Q36424457-96D067C4-F2D2-40F7-957D-0CBBA341AC6B wds:Q36424457-9FC60BD5-4E82-4971-ABE7-9A6651EDBF03 wds:Q36424457-6D1D4828-CECD-4D17-8FC3-A15D8E23B8AA wds:Q36424457-6E34B283-A450-4CCD-BBCF-AB37F13A0D7B wds:Q36424457-714053A1-FBBB-4E1E-87A4-7CB50E921100 wds:Q36424457-7560365E-C6DE-4876-819A-2FFF928B68C1 wds:Q36424457-7F5C28A8-A194-4B38-8268-C8E84BC3E2DF wds:Q36424457-82BA2E77-CA13-46BA-9824-5495364D744E wds:Q36424457-830A69BB-3C73-4B11-9103-C20FE03A9255 wds:Q36424457-86AF68FB-FB0B-413B-AC0E-C4D2FCAA792B wds:Q36424457-F390A22E-4C10-47D5-B715-0C3E27510913 wds:Q36424457-F3D858E9-566B-41BB-B490-A4C5B7E2A332 wds:Q36424457-F6B65FF1-D6D0-4FE7-B7C8-6610D3034533 wds:Q36424457-F8CDB285-67B5-4B78-8C65-C5E6F55B4C26 wds:Q36424457-FE4CC694-10F4-44C3-879A-9085403084CF wds:Q36424457-52ECD3EB-2C1C-4FF0-858B-16E144F3806E wds:Q36424457-556E6FBF-D8AF-40A0-9808-CECBF3C2914F wds:Q36424457-5662D271-B477-41F7-AAE9-9DA5D64238A2 wds:Q36424457-5729F499-692A-46AE-BC84-1090EBBEC5DA wds:Q36424457-601CD8D5-9B59-4015-AF33-7A2E675194DF wds:Q36424457-60EFACA0-2F20-4E6B-B7D7-633DF9CE4F2E wds:Q36424457-3C9E3DE7-9337-4B1E-9483-51C329822149 wds:Q36424457-400C9412-716D-4EAF-BFB6-D33E670F26A3 wds:Q36424457-44437069-0B21-4863-BEA0-EEC22EF28D0E wds:Q36424457-10481F05-967B-44BF-BA57-D0FE12373EA5 wds:Q36424457-10968C17-F822-42A3-A5A8-CAA7739B4117 wds:Q36424457-14B2B8D8-45F0-4BA7-98C2-0F6605B85A75 wds:Q36424457-14B5F2D1-BE4F-45C2-A0F0-DB52F318F284 wds:Q36424457-1EF483AD-9659-41F8-A3A9-0186B4EB92AE wds:Q36424457-014EB4AF-ADF7-4297-BF81-78BA6D1FC9B1 wds:Q36424457-026109DE-B224-4940-B50F-CC021F4F2357 wds:Q36424457-060B9937-D701-42F8-B59B-B2ECEB7CD770 wds:Q36424457-07299812-73B2-4F00-98C0-C441EE931880 wds:Q36424457-0AA36E47-1450-4C33-95BB-C907C1BC41E9
wdt:P2860
wd:Q46414093 wd:Q42951992 wd:Q35126780 wd:Q35688105 wd:Q46905258 wd:Q34720776 wd:Q36592901 wd:Q35769387 wd:Q34568768 wd:Q73589856 wd:Q28245903 wd:Q36702469 wd:Q80123195 wd:Q28269561 wd:Q51916228 wd:Q51757265 wd:Q49222689 wd:Q24545563 wd:Q83369620 wd:Q50506048 wd:Q36375691 wd:Q50951242 wd:Q41151732 wd:Q39172877 wd:Q24523983 wd:Q34657946 wd:Q29614964 wd:Q40649182 wd:Q37455410 wd:Q43067713 wd:Q36712856 wd:Q84123403 wd:Q28239239 wd:Q80556293 wd:Q37119242 wd:Q37411023 wd:Q53529956 wd:Q72634523 wd:Q34452441 wd:Q36958130 wd:Q54263427 wd:Q34575452 wd:Q24553334 wd:Q34561066 wd:Q29614931 wd:Q40438027 wd:Q79860990 wd:Q45158606 wd:Q81117261 wd:Q80381830
p:P2093
wds:Q36424457-6163229C-C7E5-44FA-B519-57BAB6C1C0F0 wds:Q36424457-6B823703-A35E-4E6C-AF21-EFD987C8F572 wds:Q36424457-4521A7AB-33C3-49C2-970F-0526A1082519
wdt:P2093
Myung Hun Yoon Hee Seung Chin Haeng Ku Kang
rdfs:label
Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population
skos:prefLabel
Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population
schema:name
Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population
p:P50
wds:Q36424457-A1189448-7024-4DE0-A517-9FC689032605
wdt:P50
wd:Q43182627
p:P1476
wds:Q36424457-23B6BF61-D2F6-452C-9D3E-18FABC063B50
wdt:P1476
Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population
p:P304
wds:Q36424457-D89B1A1A-4F7C-4990-8774-5F4105C6DF53
wdt:P304
414-422
p:P31
wds:Q36424457-FB518629-8A0F-4DCE-97E2-5528BBE17797
wdt:P31
wd:Q13442814
p:P921
wds:Q36424457-F5FFAA8B-6BE1-44DC-BAF9-966F35C6F428 wds:Q36424457-0BFF626B-F6D4-48D5-AD33-0BD1DD665B7C
wdt:P921
wd:Q413299 wd:Q27429789
p:P698
wds:Q36424457-4615E02B-911D-4715-A11B-CB603D575915
wdtn:P698
n11:23204795
wdt:P698
23204795
p:P1433
wds:Q36424457-43A368E6-12F1-4657-BA46-B6BA36127A73
wdt:P1433
wd:Q26841926
p:P433
wds:Q36424457-BFC028C2-519F-461D-8D25-2606BBF9457B
p:P478
wds:Q36424457-FED83B81-59C6-4E37-9C5F-BC26E305199D
wdt:P433
6
wdt:P478
26
p:P356
wds:Q36424457-1CF97093-F257-44D0-918C-1D6270B2232C
wdtn:P356
n12:KJO.2012.26.6.414
wdt:P356
10.3341/KJO.2012.26.6.414
p:P275
wds:Q36424457-3f786907-87cb-4be6-a692-039ca1e00b12
p:P6216
wds:Q36424457-96733500-0c2c-4b0c-a422-834a89d0ec7a
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P5875
wds:Q36424457-A9CC0F50-D985-4BA3-9E6B-C9601A310BDB
wdt:P5875
233830709
p:P932
wds:Q36424457-B1A6DCCF-3862-43FF-8884-30FE7B84A333
wdt:P932
3506814